Answers are grounded in this paper and cite their sources.
Objectives Rubinstein‐Taybi syndrome (RTS) is a rare disorder characterized by intellectual disability, poor growth, distinctive facial features, and gastrointestinal (GI) symptoms. While dysphagia and feeding difficulties are well recognized in RTS, the prevalence and clinical significance of eosinophilic esophagitis (EoE) in this population remains unclear. Methods We conducted a retrospective case series at a single pediatric tertiary care center (2012–2022) collecting demographic, genetic, clinical, endoscopic, and histopathological data. Results Twenty‐seven patients with RTS were identified; 15 (56%) had an identifiable genetic variant (12 with CREBBP and 3 with EP300 ). Seventeen patients (63%) had GI symptoms and 8 (30%) underwent endoscopy. Four patients (15%) were diagnosed with EoE, with one patient also having eosinophilic gastritis and eosinophilic duodenitis. Age at diagnosis ranged from 8 months to 23 years. Presenting symptoms included food impaction, vomiting, dysphagia, and poor weight gain. Three of the 4 patients had RTS type 1 ( CREBBP variant gene). Treatments included proton pump inhibitors, swallowed steroids, and dietary elimination with variable responses. Compared with the general population, the odds of EoE in our RTS cohort were 121‐fold higher (odds ratio = 121.6, 95% confidence interval: 13.1–1131.0, p < 0.0001). Conclusion There is a markedly increased prevalence of EoE in patients with RTS. Early recognition and evaluation of GI symptoms with endoscopic assessment is important to enable timely diagnosis, optimize management, and reduce the risk of EoE‐related complications. Further research is needed to understand the underlying genetic and immunologic mechanisms linking RTS and EoE.
No takes yet. Share an insight, caveat, or question.
Husain et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: